Chitosan nanoparticles for the linear release of model cationic peptide

Pharmaceutical Research

Volumn 32, Issue 7, 2015, Pages 2259-2265

  Piras, Anna Maria ^a   Sandreschi, Stefania ^a   Maisetta, Giuseppantonio ^a   Esin, Semih ^a   Batoni, Giovanna ^a   Chiellini, Federica ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

antimicrobial peptides; chitosan; drug delivery; linear release; nanoparticles

Indexed keywords

ANTIMICROBIAL CATIONIC PEPTIDE; CHITOSAN NANOPARTICLE; JAPONICIN 1 PEPTIDE; MASTOPARAN PEPTIDE; MEUCIN PEPTIDE; TEMPORIN PEPTIDE; UNCLASSIFIED DRUG; ARG-PRO-PHE-HIS-LEU-LEU-VAL-TYR-AMC; CHITOSAN; COUMARIN DERIVATIVE; DRUG CARRIER; NANOPARTICLE; OLIGOPEPTIDE;

ARTICLE; CONTROLLED RELEASE FORMULATION; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RELEASE; ENZYMATIC ASSAY; GELATION; MATHEMATICAL MODEL; NANOENCAPSULATION; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; CHEMICAL PHENOMENA; CHEMISTRY; MEDICINAL CHEMISTRY; STATISTICAL MODEL;

ANTIMICROBIAL CATIONIC PEPTIDES; CHEMISTRY, PHARMACEUTICAL; CHITOSAN; COUMARINS; DRUG CARRIERS; DRUG COMPOUNDING; DRUG LIBERATION; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; LINEAR MODELS; NANOPARTICLES; OLIGOPEPTIDES;

EID: 84930178589     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-014-1615-9     Document Type: Article

References (31)

1. Conlon JM, Mechkarska M, Lukic ML, Flatt PR. Potential therapeutic applications of multifunctional host-defense peptides from frog skin as anti-cancer, anti-viral, immunomodulatory, and anti-diabetic agents. Peptides. 2014;57:64-77.
2. Hancock R. Cationic antimicrobial peptides: towards clinical applications. Exp Opin Invest Drugs. 2000;9(8):1723-9.
3. Henriksen J, Etzerodt T, Gjetting T, Andresen T. Side chain hydrophobicity modulates therapeutic activity and membrane selectivity of antimicrobial peptide mastoparan-X. PLoS ONE. 2014;9(3):e91007.
4. Jiang Z, Vasil AI, Gera L, Vasil ML, Hodges RS. Rational design of alpha-helical antimicrobial peptides to target Gram-negative pathogens, Acinetobacter baumannii and Pseudomonas aeruginosa: utilization of charge, 'specificity determinants', total hydrophobicity, hydrophobe type and location as design parameters to improve the therapeutic ratio. Chem Biol Drug Des. 2011;77(4):225-40.
5. Sato H, Feix JB. Peptide-membrane interactions and mechanisms of membrane destruction by amphipathic alpha-helical antimicrobial peptides. Biochim Biophys Acta. 2006;1758(9):1245-56.
6. Yeung AY, Gellatly S, Hancock RW. Multifunctional cationic host defence peptides and their clinical applications. Cell Mol Life Sci. 2011;68(13):2161-76.
7. Brandelli A. Nanostructures as promising tools for delivery of antimicrobial peptides. Mini Rev Med Chem. 2012;12:731-41.
8. Xiong MH, Bao Y, Yang XZ, Zhu YH, Wang J. Delivery of antibiotics with polymeric particles. Adv Drug Deliv Rev. 2014.
9. Denkbas EBOR. Perspectives on: chitosan drug delivery systems based on their geometries. J Bioact Compat Polym. 2006;21:351-68.
10. Su F-Y, Lin K-J, Sonaje K, Wey S-P, Yen T-C, Ho Y-C, et al. Protease inhibition and absorption enhancement by functional nanoparticles for effective oral insulin delivery. Biomaterials. 2012;33(9):2801-11.
11. Yang S-J, Lin F-H, Tsai H-M, Lin C-F, Chin H-C, Wong J-M, et al. Alginate-folic acid-modified chitosan nanoparticles for photodynamic detection of intestinal neoplasms. Biomaterials. 2011;32(8):2174-82.
12. Piras AM, Maisetta G, Sandreschi S, Esin S, Gazzarri M, Batoni G, et al. Preparation, physical-chemical and biological characterization of chitosan nanoparticles loaded with lysozyme. Int J Biol Macromol. 2014;67:124-31.
13. Gan Q, Wang T. Chitosan nanoparticle as protein delivery carrier - systematic examination of fabrication conditions for efficient loading and release. Colloids Surf B: Biointerfaces. 2007;59:24-34.
14. Cho J, Heuzey M, Bégin A, Carreau PJ. Physical gelation of chitosan in the presence of β-glycerophosphate: the effect of temperature. Biomacromolecules. 2005;6:3267-75.
15. Murakami K, Ohsawa T, Hirose S, Takada K, Sakakibara S. New fluorogenic substrates for renin. Anal Biochem. 1981;110(1):232-9.
16. Eckert R. Road to clinical efficacy: challenges and novel strategies for antimicrobial peptide development. Rev Future Microbiol. 2011;6(6):635-51.
17. Isaacson T, Soto A, Iwamuro S, Knoop FC, Conlon JM. Antimicrobial peptides with atypical structural features from the skin of the Japanese brown frog Rana japonica. Peptides. 2002;23(3):419-25.
18. Mangoni ML, Saugar JM, Dellisanti M, Barra D, Simmaco M, Rivas L. Temporins, small antimicrobial peptides with leishmanicidal activity. J Biol Chem. 2005;280(2):984-90.
19. Gao B, Sherman P, Luo L, Bowie J, Zhu S. Structural and functional characterization of two genetically related meucin peptides highlights evolutionary divergence and convergence in antimicrobial peptides. FASEB J. 2009;23(4):1230-45.
20. Sample CJ, Hudak KE, Barefoot BE, Koci MD, Wanyonyi MS, Abraham S, et al. A mastoparan-derived peptide has broad-spectrum antiviral activity against enveloped viruses. Peptides. 2013;48:96-105.
21. Peppas NA. Analysis of Fickian and non-Fickian drug release from polymers. Pharm Acta Helv. 1985;60(4):110-1.
22. Baker R, Lonsdale H. Controlled release of biologically active agents. New York: Plenum Press; 1974. p. 15-72.
23. Gibaldi M, Feldman S. Establishment of sink conditions in dissolution rate determinations. Theoretical considerations and application to nondisintegrating dosage forms. J Pharm Sci. 1967;56(10):1238-42.
24. Thomas D, Schultz P, Steven AC, Wall JS. Mass analysis of biological macromolecular complexes by STEM. Biol Cell. 1994;80(2-3):181-92.
25. Ritger PL, Peppas NA. A simple equation for description of solute release II. Fickian and anomalous release from swellable devices. J Control Release. 1987;5(1):37-42.
26. Ritger PL, Peppas NA. A simple equation for description of solute release I. Fickian and non-fickian release from non-swellable devices in the form of slabs, spheres, cylinders or discs. J Control Release. 1987;5(1):23-36.
27. Ko JA, Park HJ, Hwang SJ, Park JB, Lee JS. Preparation and characterization of chitosan microparticles intended for controlled drug delivery. Int J Pharm. 2002;249(1-2):165-74.
28. Gan Q, Wang T, Cochrane C, McCarron P. Modulation of surface charge, particle size and morphological properties of chitosan-TPP nanoparticles intended for gene delivery. Colloids Surf B: Biointerfaces. 2005;44(2-3):65-73.
29. Yokosawa H, Ito H, Murata S, Ishii S. Purification and fluorometric assay of proteinase A from yeast. Anal Biochem. 1983;134(1):210-5.
30. Burrell M, Sweeney P, Walker J. Proteolytic enzymes for peptide production. In: Press H, editor. Enzymes of molecular biology. 1993. p. 277.
31. Yoksan R, Chirachanchai S. Amphiphilic chitosan nanosphere: studies on formation, toxicity, and guest molecule incorporation. Bioorg Med Chem. 2008;16(5):2687-96.